Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:S133-S135
Published online before print December 8, 2008, doi: 10.1161/STROKEAHA.108.533703
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3_suppl_1/S133    most recent
STROKEAHA.108.533703v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, L. B.
Related Collections
Right arrow Animal models of human disease
Right arrow Other Stroke Treatment - Medical

(Stroke. 2009;40:S133.)
© 2009 American Heart Association, Inc.


Rehabilitation

Amphetamine Trials and Tribulations

Larry B. Goldstein, MD, FAAN, FAHA

From the Department of Medicine (Neurology), Duke Stroke Center, Center for Clinical Health Policy Research, Duke University Medical Center and Durham VA Medical Center, Durham, NC.

Correspondence to Larry B. Goldstein, MD, FAAN, FAHA, Box 3651, Duke University Medical Center, Durham, NC 27710. E-mail golds004{at}mc.duke.edu

Background— Laboratory experiments conducted since the 1940s show that amphetamine combined with task-relevant experience improves postbrain injury behavioral outcomes. Several small clinical trials evaluated the approach as a means of improving poststroke recovery.

Results of Review— In laboratory studies, the effect of amphetamine on recovery depends on the location and extent of brain injury, the dosing and timing of amphetamine, and the type, intensity, and timing of concomitant behavioral training. The small clinical trials conducted to date vary considerably in critical aspects of their designs and are largely negative.

Conclusion— The question of whether d-amphetamine combined with physiotherapy is of any clinical value remains unanswered.


Key Words: amphetamine • stroke • recovery • humans